Ionis Pharmaceuticals Inc (IONS)
33.94
-1.46
(-4.11%)
USD |
NASDAQ |
Nov 21, 16:00
33.94
0.00 (0.00%)
After-Hours: 20:00
Ionis Pharmaceuticals Debt to Equity Ratio: 1.930 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.930 |
| June 30, 2024 | 4.842 |
| March 31, 2024 | 4.301 |
| December 31, 2023 | 3.317 |
| September 30, 2023 | 4.055 |
| June 30, 2023 | 3.071 |
| March 31, 2023 | 2.434 |
| December 31, 2022 | 2.078 |
| September 30, 2022 | 2.06 |
| June 30, 2022 | 1.958 |
| March 31, 2022 | 1.722 |
| December 31, 2021 | 1.596 |
| September 30, 2021 | 2.416 |
| June 30, 2021 | 2.198 |
| March 31, 2021 | 1.337 |
| December 31, 2020 | 1.223 |
| September 30, 2020 | 0.5776 |
| June 30, 2020 | 0.573 |
| March 31, 2020 | 0.5731 |
| December 31, 2019 | 0.5234 |
| September 30, 2019 | 0.4911 |
| June 30, 2019 | 0.5094 |
| March 31, 2019 | 0.5277 |
| December 31, 2018 | 0.5992 |
| September 30, 2018 | 0.8712 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.8763 |
| March 31, 2018 | 1.996 |
| December 31, 2017 | 2.110 |
| September 30, 2017 | 1.898 |
| June 30, 2017 | 2.396 |
| March 31, 2017 | 2.519 |
| December 31, 2016 | 5.027 |
| September 30, 2016 | 2.922 |
| June 30, 2016 | 3.612 |
| March 31, 2016 | 2.500 |
| December 31, 2015 | 1.939 |
| September 30, 2015 | 1.597 |
| June 30, 2015 | 1.286 |
| March 31, 2015 | 1.381 |
| December 31, 2014 | 1.457 |
| September 30, 2014 | 0.4508 |
| June 30, 2014 | 0.419 |
| March 31, 2014 | 0.4063 |
| December 31, 2013 | 0.3973 |
| September 30, 2013 | 0.3704 |
| June 30, 2013 | 0.3668 |
| March 31, 2013 | 0.7237 |
| December 31, 2012 | 0.7878 |
| September 30, 2012 | 1.33 |
| June 30, 2012 | 1.497 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.5234
Minimum
Dec 2019
4.842
Maximum
Jun 2024
2.139
Average
2.009
Median
Debt to Equity Ratio Benchmarks
| Biogen Inc | 0.3847 |
| Alnylam Pharmaceuticals Inc | 31.64 |
| Biomarin Pharmaceutical Inc | 0.1098 |
| Amicus Therapeutics Inc | 2.178 |
| Arbutus Biopharma Corp | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 3.081B |
| Total Liabilities (Quarterly) | 2.419B |
| Shareholders Equity (Quarterly) | 662.47M |
| Current Ratio | 8.910 |
| Net Debt Paydown Yield | 0.12% |